VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 210 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $374,000 | -63.2% | 14,681 | -62.8% | 0.01% | -54.5% |
| Q1 2022 | $1,015,000 | -58.4% | 39,458 | -32.2% | 0.01% | -52.2% |
| Q4 2021 | $2,437,000 | -1.7% | 58,200 | +2.1% | 0.02% | -4.2% |
| Q3 2021 | $2,480,000 | -13.3% | 56,991 | -5.8% | 0.02% | -7.7% |
| Q2 2021 | $2,860,000 | -15.0% | 60,488 | -7.8% | 0.03% | -16.1% |
| Q1 2021 | $3,363,000 | +51.1% | 65,586 | -21.1% | 0.03% | +47.6% |
| Q4 2020 | $2,226,000 | -18.4% | 83,139 | +4.6% | 0.02% | -30.0% |
| Q3 2020 | $2,729,000 | – | 79,505 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
| Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
| CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
| Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
| SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
| Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
| SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
| DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |